Elevatus Welath Management Eli Lilly & CO Transaction History
Elevatus Welath Management
- $292 Billion
- Q4 2024
A detailed history of Elevatus Welath Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Elevatus Welath Management holds 644 shares of LLY stock, worth $543,709. This represents 0.17% of its overall portfolio holdings.
Number of Shares
644
Previous 4,923
86.92%
Holding current value
$543,709
Previous $4.36 Billion
88.6%
% of portfolio
0.17%
Previous 1.43%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
4,229Shares Held
755MCall Options Held
9.22MPut Options Held
10.9M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$81.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$62.7 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$43.3 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$29 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $802B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...